Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days

スポンサーリンク

概要

• 論文の詳細を見る
• 2005-10-10

著者

• YAMADA Yasuhide

  Gastrointestinal Oncology Division, National Cancer Center Hospital

• Yamada Y

  Gastrointestinal Oncology Division National Cancer Center Hospital

• Yamada Yasuhide

  国立がんセンター中央病院 消化管内科グループ

• Yamada Yasuhide

  国立がんセンター中央病院

• Yamada Yasuhide

  Medical Oncology Division National Cancer Center Hospital

• Tamura T

  Division Of Internal Medicine National Cancer Center Hospital

• Yamamoto Noboru

  国立医薬品食品衛生研究所

• Yamamoto N

  Thoracic Oncology Division National Cancer Center Hospital National Cancer Center

• Tamura Tomohide

  国立がんセンター中央病院 腫瘍内科

• Tamura Tomohide

  国立がんセンター中央病院 相談支援センター

• Tamura T

  National Cancer Center Hospital Tokyo

• Tamura Tomohide

  Medical Oncology National Cancer Center Hospital

• Tamura Tomohide

  Medical Oncology Division National Cancer Center Hospital

• YAMAMOTO Noboru

  Medical Oncology Division, National Cancer Center Hospital

• SHIMOYAMA Tatsu

  Medical Oncology Division, National Cancer Center Hospital

• HORIIKE Atsushi

  Medical Oncology Division, National Cancer Center Hospital

• FUJISAKA Yasuhito

  Medical Oncology Division, National Cancer Center Hospital

• TAKAYAMA Kyoko

  Medical Oncology Division, National Cancer Center Hospital

• SAKAMOTO Terumi

  Medical Oncology Division, National Cancer Center Hospital

• NISHIOKA Yuki

  Clinical Research Center, Eisai Company

• YASUDA Sanae

  Clinical Research Center, Eisai Company

• Horiike Atsushi

  Medical Oncology Division National Cancer Center Hospital

• Fujisaka Yasuhito

  Medical Oncology Division National Cancer Center Hospital

• Tagawa Toshiaki

  国立がんセンター中央病院 消化器内科

• Shimoyama Tatsu

  Medical Oncology Division National Cancer Center Hospital

• Yamada Yasuhide

  Division Of Gastrointestinal Oncology National Cancer Center Hospital

• Tamura Tomohide

  Division Of Internal Medicine National Cancer Center Hospital

• Tamura Tomohide

  National Cancer Center

• Yamada Yasuhide

  国立がんセンター中央病院 消化管内科

• Yasuda Sanae

  Clinical Research Center Eisai Company

• Nishioka Yuki

  Clinical Research Center Eisai Company

• Takayama Kyoko

  Medical Oncology Division National Cancer Center Hospital

• Yamamoto Nobuko

  Department Of Internal Medicine National Cancer Center Hospital

• Yamamoto N

  College Of General Education Kyoto University

• Sakamoto Terumi

  Medical Oncology Division National Cancer Center Hospital

関連論文

• Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
• Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences
• Adipocytokine levels in gastric cancer patients : resistin and visfatin as biomarkers of gastric cancer
• LACK OF MODIFYING EFFECTS OF EUGENOL ON DEVELOPMENT OF LUNG PROLIFERATIVE LESIONS INDUCED BY URETHANE IN TRANS-GENIC MICE CARRYING THE HUMAN PROTOTYPE c-Ha-ras GENE
• Difference in the Types of Uterine Tumors between Heterozygous p53-deficient and Wild Type CBA Mice Treated with Ethinylestradiol after N-ethyl-N-nitrosourea Initiation
• 日本人におけるGSTT1及びGSTM1の遺伝子多型の同定及びハプロタイプ構造の解析
• Twenty Novel Genetic Variations and Haplotype Structures of the DCK Gene Encoding Human Deoxycytidine Kinase (dCK)
• Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
• Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
• 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
• Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
• Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days
• Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
• Three novel single nucleotide polymorphisms in UGT1A10
• Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer
• Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples
• Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil
• Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer
• Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts
• Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer
• GONADAL TOXICITY OF AN ETHANOL EXTRACT OF PSORALEA CORYLIFOLIA IN A RAT 90-DAY REPEATED DOSE STUDY
• The Utility of N-nitrosamines as Initiators for a 26-Week Rat Two-Stage Nasal Carcinogenesis Model
• Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
• Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells
• A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
• Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway
• Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models
• Reversal of Cisplatin Resistance by the 1,4-Benzothiazepine Derivative, JTV-519
• CPT-11 Alters the Circadian Rhythm of Dihydropyrimidine Dehydrogenase mRNA in Mouse Liver
• High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients
• Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors
• Adipocytokines as new promising markers of colorectal tumors : Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer
• Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
• The role of a common TNNT2 polymorphism in cardiac hypertrophy
• TIME COURSE OBSERVATION OF THYROID PROLIFERATIVE LESIONS AND SERUM LEVELS OF RELATED HORMONES IN RATS TREATED WITH KOJIC ACID AFTER DHPN INITIATION
• Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity
• What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
• Problems with Registration-Directed Clinical Trials for Lung Cancer in Japan
• Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
• Tumor response to chemotherapy : The validity and reproducibility of RECIST guidelines in NSCLC patients
• INHIBITORY EFFECTS OF REPEATED INTRAVENOUS INJECTIONS OF DEXAMETHASONE ON PULMONARY TOXICITY OF A NEW MITOMYCIN C ANALOGUE, KW-2149, IN A NOVEL RAT MODEL
• Inhibitory effects of dexamethasone on pulmonary toxicity of a new mitomycin C analogue KW-2149 in a novel rat model.
• Prospective Evaluation of the Feasibility of Cisplatin-based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions
• DOSE-THRESHOLD FOR THYROID TUMOR-PROMOTING EFFECTS OF ORALLY AMINISTERED KOJIC ACID IN RATS AFTER INITIATION WITH N-bis(2-HYDROXYPROPYL) NITROSAMINE
• High-Pressure Cell for Neutron Scattering
• Neutron Diffraction Study on Crystal and Magnetic Structures of α-Mn (Cr) and α-Mn (Fe) Alloys
• P-39 Effect of t-buthylhydroquinone and sodium nitrite alone or in combination on the forestomach of rasH2 mice.(Proceedings of the 27th Annual Meeting)
• 21B-04-1 Preliminary Repeated Dose (28 Days) Oral Toxicity Study of Flutamide to Establish the Efficacy of the "Enhanced OECD Test Guideline 407" in Rats.
• Absence of Tumor Promoting Activity of Xylazine in a Two-stage Nasal Carcinogenesis Model in N-bis(2-hydroxypropyl)nitrosamine-treated Rats
• P-67 Early changes of thyroid and in rats given a single administration of diisopropanolnitrosamine.(Proceedings of the 27th Annual Meeting)
• O-14 Mechanistic studies on testicular toxicity of Psoralea corylifolia extract in rats.(Proceedings of the 27th Annual Meeting)
• 21B-10-1 Triphenylboron compounds affect both lymphoid and hematopoietic organs in rats.
• Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)
• Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities
• MECHANISM OF FK506-INDUCED GLUCOSE INTOLERANCE IN RATS
• Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
• Translational and clinical studies of target-based cancer therapy
• Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors
• P7-07 Is emulsification of the test substance with Freund's complete adjuvant(FCA) necessary in the guinea pig maximization test?(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTATION
• EFFECTS OF pH AND OSMOLALITY ON PHLEBITIC POTENTIAL OF INFUSION SOLUTIONS FOR PERIPHERAL PARENTERAL NUTRITION
• Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
• On Perturbation Expansion of Field Theory in Accelerated System and the Thermofield Dynamics : Particles and Fields
• A Comment on Quantum Fluctuations around Solitons
• A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
• ACUTE TOXICITY TESTS OF MOFEZOLAC (N-22) IN MICE AND RATS
• Genetic Polymorphisms of FCGRT Encoding FcRn in a Japanese Population and Their Functional Analysis
• Plasma concentrations of VCAM-1 and PAI-1 : A predictive biomarker for post-operative recurrence in colorectal cancer
• "P-1 Effects of pH and Osmolality on Phlebitic Potential of infusion Solutions for Peripheral Parenteral Nutrition.
• Mesoblastic Nephroma : A Case Report of Prenatal Detection by MR Imaging
• Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake : a retrospective study
• Innovator and generic cisplatin formulations : Comparison of renal toxicity
• Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1^*28 and/or UGT1A1^*6 polymorphisms
• Distal Promoter Regions Are Responsible for Differential Regulation of Human Orosomucoid-1 and -2 Gene Expression and Acute Phase Responses
• Behavioral alterations in rats born to mothers exposed to a single dose of thyrotropin-releasing hormone during pregnancy.
• Prenatal exposure of rats to phenytoin develops supersensitivity to haloperidol in adulthood.
• Persistence of hypersensitivity to lethal effect of injected calcium chloride for ten generations of rats raised from parathyroidectomized mothers.
• Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer : AVASIRI trial

もっと見る 閉じる

スポンサーリンク